
What if the apparent calm is not a sign that the pandemic is ending, but a sign that it is changing?
What if the virus is not losing, but adapting to the very immunity meant to stop it?
And what if the increasing prevalence of long COVID is not a virus-specific side-effect, but the first tangible symptom of an immune system drifting out of control?
Executive Summary
Chronic illness after viral infection is not always caused by high viral load-it can result from a misdirected immune system.
In highly COVID-19 (C-19)-vaccinated populations, immunity may be suboptimal at the population level, allowing continued viral transmission.
This sustained transmission drives viral immune escape and repeated immune refocusing, weakening control over the virus.
This process links vaccine breakthrough infections, immune escape and long COVID in highly C-19-vaccinated populations.
The current ‘calm’ may therefore be misleading; it can mask a system that is becoming increasingly unstable beneath the surface, potentially evolving toward a more virulent phase (HiViCron).
Why the Current Calm May Be an Illusion
In my previous Substack, I argued that the apparent epidemiological calm we are currently experiencing may not reflect true viral control, but rather a temporary and potentially deceptive equilibrium (https://voiceforscienceandsolidarity.substack.com/p/why-the-current-calm-in-sars-cov).
If viral transmission continues-albeit less visibly-the virus does not stop evolving. It continues to explore new ways to adapt within a constrained environment shaped by suboptimal population-level immunity (Note: this is not what is meant by herd immunity!).
What appears as stability may, in reality, be a system under tension-quietly accumulating evolutionary pressure that could ultimately be released in a phase transition toward a qualitatively different viral behavior.
A Different Way to Understand Chronic Illness After Infection
We often assume that long-lasting symptoms after infection are caused by a virus that simply persists and replicates at high levels. But there is another possibility. The problem may lie in the way the immune system is being repeatedly redirected.
Instead of mounting a stable and focused response, the immune system may begin to:
shift its attention
chase different, less vulnerable viral targets
lose coherence over time
This process, called ‘immune refocusing’, can prevent proper viral clearance while keeping the immune system activated.
The Role of Highly C-19–Vaccinated Populations
In highly C-19-vaccinated populations, immune responses are often shaped by repeated exposure to similar viral antigens. While this can provide short-term protection, it may also create conditions where:
immunity is not optimally aligned with evolving variants
the virus is placed under selective population-level immune pressure to escape
immune responses become increasingly redirected rather than resolved
This does not stop transmission but sustains it while mitigating symptoms of acute disease. And sustained transmission is the key driver of everything that follows.
A Self-Reinforcing Feedback Loop
This creates a feedback loop:
Suboptimal population-level immunity pressures the virus
The virus adapts to escape
The immune system refocuses on other -more conserved but less immunogenic- epitopes (mostly on Spike protein)
Control becomes less effective
Transmission continues
Over time, this loop intensifies. And as described previously, it begins to tighten into a closed system, one that no longer moves toward equilibrium, but toward instability (https://voiceforscienceandsolidarity.substack.com/p/why-the-current-calm-in-sars-cov).
The virus is no longer evolving freely-it is navigating an increasingly narrow path, like passing through a biological ‘Strait of Hormuz’, where only highly adapted variants can pass through and continue evolving in a hostile environment.
This is not a stable situation. It is a volatile one, and precisely the type of system in which phase transitions can occur.
Why This Explains Long COVID
Within this framework, long COVID is not just ‘damage left behind.’ It may reflect an ongoing, unresolved interaction between the circulating virus and the continuously challenged immune system.
In some individuals:
viral remnants or reservoirs persist
the immune system keeps responding
but keeps changing its target
The result is:
chronic immune inflammation
fluctuating symptoms
involvement of multiple organs
Long COVID becomes the clinical expression of a system that cannot properly resolve infection and may already be operating beyond its stable regime.
Why Ongoing Transmission Matters
This is the critical point. The more the virus continues to circulate:
the more often the immune system is challenged
the more frequently it is forced to refocus
the greater the chance of immune dysregulation and, consequently, the prevalence of immunopathology and cancers
This means that long COVID is not just about past infections. Its prevalence may increase with ongoing transmission, while at the same time raising the likelihood that the system moves closer to a critical threshold for a dangerous transition of the virus .
The Problem with Current Public Health Thinking
Public health strategies have largely focused on reducing severe acute disease. But this may overlook a deeper and more consequential problem. If transmission continues unchecked in highly vaccine-experienced populations, we may be:
sustaining viral evolution
accelerating immune escape
and progressively destabilizing immune control
Ignoring this dynamic is not merely an oversight, it is a risky gamble and reckless attitude, because it allows a self-reinforcing cycle of:
immune escape
misdirected immunity
chronic disease
to become entrenched-while the system itself moves closer to a dangerous tipping point.
The Bigger Risk: The Emergence of HiViCron
As this process continues, the system may approach a phase transition. At that point, even small viral changes could produce disproportionately large biological ‘gain-of-function’ effects.
This is the context in which the emergence of a highly adapted, immune-evasive and likely much more virulent lineage-what I have referred to as HiViCron-becomes highly plausible in highly C-19-vaccinated populations. Such a transition would not be accidental. It would be the logical outcome of a system driven for too long by sustained transmission, suboptimal collective immune pressure, and progressive immune misdirection.
Final Thought
Given the evolutionary dynamics of this ‘gain-of-function’ pandemic, long COVID may not be the end of the problem.
Its increasing prevalence may be the first clearly tangible signal that something is no longer normal-namely, that the evolutionary dynamics of this immune escape pandemic have driven a virus that typically causes acute, self-limiting infection to shift toward causing chronic disease, indicating that something deeper is unfolding.
This signals that the interaction between the virus and the population’s immune defense is no longer stable, but is instead caught in a vicious cycle of: adaptation à misdirection à incomplete control.
And if the current calm is indeed an illusion, then what appears manageable today may, in reality, be quietly evolving toward a fundamentally different-and potentially far more dangerous-phase of this pandemic: namely, a hyperacute wave of viral dissemination into the blood and all organ systems across all heavily C?19?vaccinated regions

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org